429 related articles for article (PubMed ID: 29413506)
21. [Pulmonary arterial hypertension in collagenoses: clinical features, epidemiology, pathogenesis, diagnosis and treatment].
Ahmadi-Simab K; Gross WL
Z Rheumatol; 2006 Jul; 65(4):297-300, 302-5. PubMed ID: 16804698
[TBL] [Abstract][Full Text] [Related]
22. Characterization of connective tissue disease-associated pulmonary arterial hypertension from REVEAL: identifying systemic sclerosis as a unique phenotype.
Chung L; Liu J; Parsons L; Hassoun PM; McGoon M; Badesch DB; Miller DP; Nicolls MR; Zamanian RT
Chest; 2010 Dec; 138(6):1383-94. PubMed ID: 20507945
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary arterial hypertension complicating connective tissue diseases.
Hassoun PM
Semin Respir Crit Care Med; 2009 Aug; 30(4):429-39. PubMed ID: 19634082
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary Hypertension in Scleroderma- Evaluation and Management.
Chennakesavulu PV; Uppaluri S; Koyi J; Jhaveri S; Avanthika C; Sakhamuri LT; Ashokbhai PK; Singh P
Dis Mon; 2023 Jul; 69(7):101468. PubMed ID: 36163292
[TBL] [Abstract][Full Text] [Related]
25. Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.
Volkmann ER; Saggar R; Khanna D; Torres B; Flora A; Yoder L; Clements PJ; Elashoff RM; Ross DJ; Agrawal H; Borazan N; Furst DE; Saggar R
Arthritis Rheumatol; 2014 Jul; 66(7):1900-8. PubMed ID: 24729406
[TBL] [Abstract][Full Text] [Related]
26. Features associated with pulmonary arterial hypertension in Chinese hospitalized systemic lupus erythematosus patients.
Xu SZ; Yan Liang ; Li XP; Li XM; Shuai ZW; Leng RX; Pan HF; Ye DQ
Clin Rheumatol; 2018 Jun; 37(6):1547-1553. PubMed ID: 29520672
[TBL] [Abstract][Full Text] [Related]
27. [Management of borderline pulmonary arterial hypertension associated with connective tissue diseases].
Yoshifuji H; Kinoshita H
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):454-61. PubMed ID: 25748129
[TBL] [Abstract][Full Text] [Related]
28. Connective tissue disease-related pulmonary arterial hypertension.
Thakkar V; Lau EM
Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):22-38. PubMed ID: 27421214
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary arterial hypertension in connective tissue diseases.
Mathai SC; Hassoun PM
Heart Fail Clin; 2012 Jul; 8(3):413-25. PubMed ID: 22748903
[TBL] [Abstract][Full Text] [Related]
30. [Systemic sclerosis associated pulmonary arterial hypertension: the pitfalls].
Hachulla E; Launay D; Le Pavec J; Mouthon L; Guillevin L; de Groote P
Presse Med; 2011 Apr; 40 Suppl 1():1S46-53. PubMed ID: 21536180
[TBL] [Abstract][Full Text] [Related]
31. Pulmonary arterial hypertension related to connective tissue disease: a review.
Ahmed S; Palevsky HI
Rheum Dis Clin North Am; 2014 Feb; 40(1):103-24. PubMed ID: 24268012
[TBL] [Abstract][Full Text] [Related]
32. Long-Term Outcomes in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry (PHAROS).
Kolstad KD; Li S; Steen V; Chung L;
Chest; 2018 Oct; 154(4):862-871. PubMed ID: 29777655
[TBL] [Abstract][Full Text] [Related]
33. Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions.
Denton CP; Humbert M; Rubin L; Black CM
Ann Rheum Dis; 2006 Oct; 65(10):1336-40. PubMed ID: 16793845
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary hypertension in connective tissue diseases: an update.
Aithala R; Alex AG; Danda D
Int J Rheum Dis; 2017 Jan; 20(1):5-24. PubMed ID: 28205373
[TBL] [Abstract][Full Text] [Related]
35. Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension.
Corrado A; Correale M; Mansueto N; Monaco I; Carriero A; Mele A; Colia R; Di Biase M; Cantatore FP
Microvasc Res; 2017 Nov; 114():46-51. PubMed ID: 28619664
[TBL] [Abstract][Full Text] [Related]
36. Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated?
Nikpour M; Stevens W; Proudman SM; Buchbinder R; Prior D; Zochling J; Williams T; Gabbay E; Nandurkar H
Intern Med J; 2013 May; 43(5):599-603. PubMed ID: 23668273
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary arterial hypertension and systemic sclerosis relation: a single centre experience.
Demir N; Şahin A; Küçükşahin O; Kayacan O; Dinçer İ; Sayın T; Karnak D; Turgay M
Heart Lung Circ; 2014 Jul; 23(7):667-73. PubMed ID: 24613044
[TBL] [Abstract][Full Text] [Related]
38. Bosentan therapy of pulmonary arterial hypertension in connective tissue diseases.
Cozzi F; Montisci R; Marotta H; Bobbo F; Durigon N; Ruscazio M; Sfriso P; Iliceto S; Todesco S
Eur J Clin Invest; 2006 Sep; 36 Suppl 3():49-53. PubMed ID: 16919011
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary Hypertension in Connective Tissue Diseases Other than Systemic Sclerosis.
Budhram B; Weatherald J; Humbert M
Semin Respir Crit Care Med; 2024 Jun; 45(3):419-434. PubMed ID: 38499196
[TBL] [Abstract][Full Text] [Related]
40. An update in pulmonary hypertension in systemic lupus erythematosus - do we need to know about it?
Pope J
Lupus; 2008 Apr; 17(4):274-7. PubMed ID: 18413406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
